MAPT and Alzheimer disease: The presence of AβOs causes changes similar to those seen in AD, including neuronal tau hyperphosphorylation, increased oxidative stress, and inhibition of synaptic plasticity, and this gives a clinical picture in the form of memory and cognitive dysfunction.